Smart Insulin Pumps Improve Blood Sugar in Newly Diagnosed Kids

What Was Studied — and Why It Matters

When a child is first diagnosed with type 1 diabetes, doctors must quickly decide which insulin delivery technology to use. This Polish study looked at whether starting children on an automated insulin delivery (AID) system — specifically the MiniMed 780G — from the very first days of diagnosis produced better results than starting them on a standard smart pump with a low-glucose safety feature (called SAP-PLGS).

This question is important because most research on AID systems involves people who have had diabetes for years. Very little data existed on using these advanced systems from day one of a diagnosis in children.

What the Researchers Did

The team reviewed records from 50 children newly diagnosed with type 1 diabetes across two medical centers. Twenty-two children used the AID system, and 28 used the standard smart pump. Researchers tracked blood sugar data at four points over 12 months: in the first two weeks, and then again at 3, 6, and 12 months.

What They Found

After one full year, the children using the automated system showed significantly better results in two key measures:

• Time in Range (TIR): The percentage of time blood sugar stayed in the healthy zone of 70–180 mg/dL was meaningfully higher in the AID group.
• Time in Tight Range (TITR): The AID group also spent more time in the even stricter ideal range of 70–140 mg/dL — a marker of very precise glucose control.

One particularly reassuring finding involved C-peptide levels — a measurement of how much insulin the child's own pancreas is still producing. There was no significant difference between the two groups here, meaning the advanced system did not appear to reduce the body's own remaining insulin production any faster than the standard pump.

What This Means for Patients and Families

For families navigating a brand-new type 1 diabetes diagnosis, this research offers encouraging news: starting with the most advanced available technology from the beginning may give children a head start on healthy blood sugar control — without any apparent downside to the body's natural insulin function.

Managing a child's diabetes requires the right supplies every step of the way. Whether your child uses an AID system or a traditional pump, MDS Diabetes carries the continuous glucose monitoring sensors, pump supplies, and diabetes management essentials that keep these devices running smoothly day after day.

Key Takeaways at a Glance

• Automated insulin delivery systems can be used safely and effectively from the moment of a type 1 diabetes diagnosis in children.
• Kids on AID systems spent more time in healthy blood sugar ranges compared to those on standard smart pumps.
• The body's remaining insulin production was preserved equally well in both groups.
• Early access to advanced technology may reduce the burden of diabetes management for both children and caregivers.

Bottom Line

Starting children with newly diagnosed type 1 diabetes on an automated insulin delivery system from day one leads to better blood sugar control after one year, without any harm to the pancreas's remaining function. If your child has recently been diagnosed, ask your diabetes care team whether an AID system is appropriate — and make sure you have a reliable supply partner like MDS Diabetes to keep all the necessary equipment stocked and ready.